Naloxone over the counter availability
Pro Research Analysisby 
Searched over 200M research papers
FDA Approval and Over-the-Counter Naloxone Availability
In March 2023, the U.S. Food and Drug Administration (FDA) approved naloxone nasal spray (Narcan) for over-the-counter (OTC) sale, making it available in drugstores, supermarkets, convenience stores, gas stations, and online without a prescription. This move is seen as a significant step in combating the opioid overdose crisis, as naloxone rapidly reverses opioid overdoses and its wider availability is expected to save many lives 134.
Impact on Pharmacy Access and Cost
Studies show that after naloxone became available OTC, same-day availability in pharmacies increased significantly. In North Carolina, for example, same-day access rose from 42.2% to 57.8% of pharmacies, and the average out-of-pocket cost for cash-paying patients dropped from $90.93 to $62.67 . However, access and cost still vary by pharmacy type, with chain pharmacies more likely to stock OTC naloxone and offer same-day pick-up compared to independent pharmacies. Rurality did not significantly affect availability or cost .
Barriers and Concerns: Price, Insurance, and Education
While OTC status increases access, concerns remain about affordability and insurance coverage. If insurers stop covering OTC naloxone, the cost could become a barrier for vulnerable populations. Experts emphasize the need for continued insurance coverage and efforts to keep prices low 1345. Additionally, there is a need for public education on recognizing opioid overdoses and proper naloxone use, as well as clear instructions included with the product 158.
Distribution Beyond Pharmacies
Despite expanded pharmacy access, many doses of naloxone are still distributed by nonretail organizations such as first responders and community groups. Standing orders in pharmacies have not always resulted in widespread availability, and awareness of these programs remains low 15. Comprehensive distribution strategies, including overdose education and harm reduction programs, are still necessary to reach the most at-risk populations 45.
Safety and Training Considerations
Some experts caution that making naloxone available OTC without proper training or counseling could pose risks, especially if used by untrained individuals or in situations involving intoxicated bystanders. Professional input and education are recommended to ensure safe and effective use 810.
Regulatory and Policy Implications
The move to OTC naloxone highlights the need to update state regulations that may no longer be relevant and to consider a "standard of care" approach for pharmacist services. This could help reduce unnecessary barriers and improve public health responses in the future .
Conclusion
The transition of naloxone to over-the-counter status marks a major advancement in the fight against opioid overdose deaths by increasing access and reducing costs. However, to maximize its life-saving potential, ongoing efforts are needed to ensure affordability, insurance coverage, public education, and comprehensive distribution, especially for the most vulnerable populations. Careful consideration of safety, training, and regulatory approaches will be essential as naloxone becomes more widely available.
Sources and full results
Most relevant research papers on this topic